Parametrica Management Ltd increased its stake in Magellan Health Inc (MGLN) by 127.92% based on its latest 2018Q1 regulatory filing with the SEC. Parametrica Management Ltd bought 3,363 shares as the company’s stock declined 6.81% with the market. The institutional investor held 5,992 shares of the health care company at the end of 2018Q1, valued at $642,000, up from 2,629 at the end of the previous reported quarter. Parametrica Management Ltd who had been investing in Magellan Health Inc for a number of months, seems to be bullish on the $2.27B market cap company. The stock increased 0.97% or $0.9 during the last trading session, reaching $93.8. About 130,485 shares traded. Magellan Health, Inc. (NASDAQ:MGLN) has risen 30.19% since June 17, 2017 and is uptrending. It has outperformed by 17.62% the S&P500. Some Historical MGLN News: 25/05/2018 – Magellan Health Boosts Repurchase Authorization to $400M, With $245.9M Remaining as of Thursday; 17/04/2018 – Magellan Rx Management Announces Results from Hemophilia Management Program in Honor of World Hemophilia Day; 26/04/2018 – Magellan Health 1Q Rev $1.81B; 07/03/2018 Magellan Health Volume Jumps More Than Six Times 20 Day Average; 24/04/2018 – MAGELLAN HEALTH INC SAYS COMPANY PLANS TO FILE A PROTEST WITH AHCA – SEC FILING; 20/04/2018 – Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals after Flooding in; 19/04/2018 – Magellan Rx Management Releases New Employer Market Insights Report; 14/05/2018 – Fidelity & Research Buys New 6.1% Position in Magellan Health; 21/05/2018 – Magellan Health Named to the Fortune 500 List of America’s Largest Companies; 26/04/2018 – MAGELLAN HEALTH INC – LOWERING ITS FULL YEAR 2018 EARNINGS GUIDANCE
Seymour Sy Kaufman increased its stake in Salesforce.Com (CRM) by 84.61% based on its latest 2018Q1 regulatory filing with the SEC. Crosslink Capital Inc bought 80,790 shares as the company’s stock rose 9.70% while stock markets declined. The hedge fund run by Seymour Sy Kaufman held 176,274 shares of the prepackaged software company at the end of 2018Q1, valued at $20.50 million, up from 95,484 at the end of the previous reported quarter. Crosslink Capital Inc who had been investing in Salesforce.Com for a number of months, seems to be bullish on the $102.83 billion market cap company. It closed at $138.41 lastly. It is up 40.20% since June 17, 2017 and is uptrending. It has outperformed by 27.63% the S&P500. Some Historical CRM News: 21/05/2018 – SALESFORCE.COM INC CRM.N : BOFA MERRILL RAISES PRICE OBJECTIVE TO $161 FROM $147; 24/04/2018 – Magnet 360 Announces Lightning Bolt Factory, for Salesforce Lightning Bolt, Empowering Companies to Deploy Faster With Partner-; 07/03/2018 – DocuSign picks banks for potential IPO in April; 29/05/2018 – SALESFORCE 1Q BILLINGS GROWTH +17%, EST. +12%; 12/04/2018 – Refocus Group Readies for Commercialization of VisAbility™ Micro lnsert System; Expands Salesforce and Manufacturing Capacity; 26/04/2018 – Marriott Intl Launches Global Customer Recognition Platform Powered by Salesforce, Providing Personalization at Scale Across All Consumer Touchpoints; 15/03/2018 – Dril-Quip Announces Retirement of Jerry M. Brooks; 20/03/2018 – MULESOFT INC – SALESFORCE WILL ACQUIRE MULESOFT FOR AN ENTERPRISE VALUE OF APPROXIMATELY $6.5 BLN; 20/03/2018 – EXCLUSIVE-SALESFORCE.COM INC CRM.N IN ADVANCED TALKS TO BUY MULESOFT INC MULE.N; 20/03/2018 – Salesforce is in advanced talks to buy MuleSoft, sources tell Reuters
Crosslink Capital Inc, which manages about $2.09 billion and $498.50 million US Long portfolio, decreased its stake in Zendesk Inc (NYSE:ZEN) by 573,742 shares to 222,456 shares, valued at $10.65M in 2018Q1, according to the filing. It also reduced its holding in Pandora Media Inc. (NYSE:P) by 1.02M shares in the quarter, leaving it with 5.64 million shares, and cut its stake in Coupa Software Inc.
Since January 3, 2018, it had 5 buys, and 216 insider sales for $165.22 million activity. Shares for $638,254 were sold by Benioff Marc. BLOCK KEITH also sold $1.20 million worth of salesforce.com, inc. (NYSE:CRM) shares. 143 salesforce.com, inc. (NYSE:CRM) shares with value of $17,984 were sold by Roos John Victor. Allanson Joe had sold 321 shares worth $36,425 on Thursday, February 22. 6,000 salesforce.com, inc. (NYSE:CRM) shares with value of $742,854 were bought by Wojcicki Susan. 345 shares valued at $39,149 were sold by Weaver Amy E on Thursday, February 22.
Among 57 analysts covering Salesforce.com (NYSE:CRM), 51 have Buy rating, 0 Sell and 6 Hold. Therefore 89% are positive. Salesforce.com had 249 analyst reports since August 21, 2015 according to SRatingsIntel. Morgan Stanley maintained the shares of CRM in report on Saturday, August 22 with “Overweight” rating. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, March 1 report. The rating was maintained by Mizuho on Thursday, May 19 with “Buy”. Roth Capital maintained the shares of CRM in report on Friday, October 27 with “Buy” rating. The stock of salesforce.com, inc. (NYSE:CRM) has “Buy” rating given on Thursday, September 1 by Citigroup. Wedbush maintained it with “Outperform” rating and $98 target in Thursday, May 19 report. The stock has “Buy” rating by Lake Street on Thursday, November 19. As per Thursday, May 19, the company rating was maintained by Deutsche Bank. The stock of salesforce.com, inc. (NYSE:CRM) has “Buy” rating given on Thursday, May 19 by Brean Capital. The company was maintained on Wednesday, November 8 by RBC Capital Markets.
More notable recent salesforce.com, inc. (NYSE:CRM) news were published by: Benzinga.com which released: “NFIB Small Business Optimism Soars. Here Are Some Companies That May Benefit” on June 13, 2018, also Fool.com with their article: “3 Reasons salesforce.com Stock Could Rise” published on June 07, 2018, Seekingalpha.com published: “Ignore Salesforce’s Valuation” on May 24, 2018. More interesting news about salesforce.com, inc. (NYSE:CRM) were released by: Fool.com and their article: “6 Reasons Salesforce Is Surging to All-Time Highs” published on June 10, 2018 as well as Fool.com‘s news article titled: “The 3 Things Salesforce Executives Can’t Stop Talking About” with publication date: June 04, 2018.
Investors sentiment increased to 1.44 in 2018 Q1. Its up 0.25, from 1.19 in 2017Q4. It is positive, as 48 investors sold CRM shares while 254 reduced holdings. 132 funds opened positions while 304 raised stakes. 608.53 million shares or 0.05% more from 608.21 million shares in 2017Q4 were reported. Bridgecreek Inv Mngmt Ltd reported 93,809 shares or 2.46% of all its holdings. Savant Capital Ltd Limited Liability Company has invested 0.07% in salesforce.com, inc. (NYSE:CRM). Calamos Wealth Mgmt Ltd Liability Company invested in 14,827 shares or 0.22% of the stock. Fincl Bank Of Nova Scotia holds 0.08% or 131,854 shares in its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 290,125 shares or 0.31% of its portfolio. Meiji Yasuda Life Ins Company accumulated 15,427 shares. Ftb Advisors owns 643 shares. Harding Loevner LP owns 130 shares or 0% of their US portfolio. Highland Capital Mngmt Lp reported 13,000 shares stake. Georgia-based Montag A & Assoc has invested 0.04% in salesforce.com, inc. (NYSE:CRM). Ls Invest Advsrs Limited Liability Corp accumulated 12,820 shares. Numerixs Investment Technologies accumulated 1.12% or 40,196 shares. Company Savings Bank holds 0.01% in salesforce.com, inc. (NYSE:CRM) or 6,519 shares. Andra Ap reported 41,400 shares. Trillium Asset Limited holds 135,722 shares or 0.87% of its portfolio.
Since January 2, 2018, it had 0 insider buys, and 11 selling transactions for $16.27 million activity. On Tuesday, January 2 the insider Rubin Jonathan N sold $1.68M. On Monday, March 5 the insider Kamal Mostafa sold $1.53M. GREGOIRE DANIEL N had sold 22,875 shares worth $2.27M on Monday, March 5.
Among 5 analysts covering Magellan Health (NASDAQ:MGLN), 4 have Buy rating, 1 Sell and 0 Hold. Therefore 80% are positive. Magellan Health had 25 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, April 27 by Leerink Swann. The stock of Magellan Health, Inc. (NASDAQ:MGLN) earned “Buy” rating by Jefferies on Monday, September 26. On Wednesday, November 23 the stock rating was maintained by Barclays Capital with “Underweight”. The firm has “Sector Perform” rating by Scotia Capital given on Tuesday, August 11. The firm has “Buy” rating by KeyBanc Capital Markets given on Wednesday, September 20. The stock has “Outperform” rating by Raymond James on Tuesday, May 1. On Friday, July 28 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating given on Thursday, March 15 by Leerink Swann. The company was maintained on Friday, March 23 by Jefferies. The rating was upgraded by KeyBanc Capital Markets to “Overweight” on Friday, July 14.
More news for Magellan Health, Inc. (NASDAQ:MGLN) were recently published by: Bizjournals.com, which released: “6 Arizona companies land on Fortune 500” on May 22, 2018. Streetinsider.com‘s article titled: “Magellan Health (MGLN) Appoints Swati Abbott and Matthew J. Simas to Board” and published on May 29, 2018 is yet another important article.